Neutrophils are essential for containment of Vibrio cholerae to the intestine during the proinflammatory phase of infection

Infection and Immunity

Volumn 80, Issue 8, 2012, Pages 2905-2913

  Queen, Jessica ^a   Fullner Satchell, Karla J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MACROPHAGE INFLAMMATORY PROTEIN 2 ALPHA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CHOLERA; DISEASE COURSE; ENTERITIS; FEMALE; IMMUNOCOMPETENCE; INFECTION; INNATE IMMUNITY; INTESTINE; MOUSE; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SPLEEN; VIBRIO CHOLERAE;

ANIMALS; CHOLERA; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; IMMUNITY, INNATE; INTESTINES; MICE; MICE, INBRED C57BL; NEUTROPENIA; NEUTROPHILS; VIBRIO CHOLERAE; VIRULENCE;

EID: 84864808706     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00356-12     Document Type: Article

References (55)

1. Ali M. 2012. The global burden of cholera. Bull. World Health Organ. 90: 209-218A.
2. Bishop AL, Camilli A. 2011. Vibrio cholerae: lessons for mucosal vaccine design. Expert Rev. Vaccines 10: 79-94.
3. Bromander A, Holmgren J, Lycke N. 1991. Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146: 2908-2914.
4. Bromander AK, Kjerrulf M, Holmgren J, Lycke N. 1993. Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells. Scand. J. Immunol. 37: 452-458.
5. Bubshait SA, Al-Turki K, Qadri MH, Fontaine RE, Cameron D. 2000. Seasonal, nontoxigenic Vibrio cholerae O1 Ogawa infections in the eastern region of Saudi Arabia. Int. J. Infect. Dis. 4: 198-202.
6. Burkart V, et al. 2002. Cholera toxin B pretreatment of macrophages and monocytes diminishes their proinflammatory responsiveness to lipopolysaccharide. J. Immunol. 168: 1730-1737.
7. Coelho A, Andrade JR, Vicente AC, Dirita VJ. 2000. Cytotoxic cell vacuolating activity from Vibrio cholerae hemolysin. Infect. Immun. 68: 1700-1705.
8. Cong Y, Oliver AO, Elson CO. 2001. Effects of cholera toxin on macrophage production of co-stimulatory cytokines. Eur. J. Immunol. 31: 64-71.
9. Daley JM, Thomay AA, Connolly MD, Reichner JS, Albina JE. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83: 64-70.
10. Domingos MO, et al. 2009. Influence of the A and B subunits of cholera toxin (CT) and Escherichia coli toxin (LT) on TNF-alpha release from macrophages. Toxicon 53: 570-577.
11. Figueroa-Arredondo P, et al. 2001. Cell vacuolation caused by Vibrio cholerae hemolysin. Infect. Immun. 69: 1613-1624.
12. Flach CF, et al. 2007. Broad upregulation of innate defense factors during acute cholera. Infect. Immun. 75: 2343-2350.
13. Fullner KJ, et al. 2002. The contribution of accessory toxins of Vibrio cholerae O1 El Tor to the proinflammatory response in a murine pulmonary cholera model. J. Exp. Med. 195: 1455-1462.
14. Fullner KJ, Mekalanos JJ. 2000. In vivo covalent cross-linking of cellular actin by the Vibrio cholerae RTX toxin. EMBO J. 19: 5315-5323.
15. Goldberg I, Mekalanos JJ. 1986. Effect of a recA mutation on cholera toxin gene amplification and deletion events. J. Bacteriol. 165: 723-731.
16. Goo SY, Han YS, Kim WH, Lee KH, Park SJ. 2007. Vibrio vulnificus IlpA-induced cytokine production is mediated by Toll-like receptor 2. J. Biol. Chem. 282: 27647-27658.
17. Gutierrez MG, et al. 2007. Protective role of autophagy against Vibrio cholerae cytolysin, a pore-forming toxin from V. cholerae. Proc. Natl. Acad. Sci. U. S. A. 104: 1829-1834.
18. Haines GK, III, Sayed BA, Rohrer MS, Olivier V, Satchell KJ. 2005. Role of Toll-like receptor 4 in the proinflammatory response to Vibrio cholerae O1 El Tor strains deficient in production of cholera toxin and accessory toxins. Infect. Immun. 73: 6157-6164.
19. Harris JB, et al. 2008. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl. Trop. Dis. 2: e221. doi: 10.1371/journal.pntd.0000221.
20. Harrison LM, et al. 2008. Vibrio cholerae flagellins induce Toll-like receptor 5-mediated interleukin-8 production through mitogen-activated protein kinase and NF-
21. Jones RM, Neish AS. 2011. Recognition of bacterial pathogens and mucosal immunity. Cell Microbiol. 13: 670-676.
22. Kaper JB, Morris JG, Jr, Levine MM. 1995. Cholera. Clin. Microbiol. Rev. 8: 48-86.
23. la Sala A, et al. 2009. Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function. J. Exp. Med. 206: 1227-1235.
24. Lee JB, Jang JE, Song MK, Chang J. 2009. Intranasal delivery of cholera toxin induces Th17-dominated T-cell response to bystander antigens. PLoS One 4: e5190. doi: 10.1371/journal.pone.0005190.
25. Lee NY, Lee HY, Lee KH, Han SH, Park SJ. 2011. Vibrio vulnificus IlpA induces MAPK-mediated cytokine production via TLR1/2 activation in THP-1 cells, a human monocytic cell line. Mol. Immunol. 49: 143-154.
26. Levine MM, et al. 1988. Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect. Immun. 56: 161-167.
27. -ΔΔCT method. Methods 25: 402-408.
28. Ma AT, McAuley S, Pukatzki S, Mekalanos JJ. 2009. Translocation of a Vibrio cholerae type VI secretion effector requires bacterial endocytosis by host cells. Cell Host Microbe 5: 234-243.
29. Ma AT, Mekalanos JJ. 2010. In vivo actin cross-linking induced by Vibrio cholerae type VI secretion system is associated with intestinal inflammation. Proc. Natl. Acad. Sci. U. S. A. 107: 4365-4370.
30. Makri S, Purdy AE, Bartlett D, Fierer J. 2007. Pathogenicity of environmental isolates of Vibrio cholerae in mice. Microbes Infect. 9: 1351-1358.
31. Marinaro M, et al. 1995. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J. Immunol. 155: 4621-4629.
32. Mathan MM, Chandy G, Mathan VI. 1995. Ultrastructural changes in the upper small intestinal mucosa in patients with cholera. Gastroenterology 109: 422-430.
33. Morris JG, Jr, et al. 1984. Isolation of nontoxigenic Vibrio cholerae O group 1 from a patient with severe gastrointestinal disease. J. Clin. Microbiol. 19: 296-297.
34. Mutreja A, et al. 2011. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature 477: 462-465.
35. Nelson EJ, Harris JB, Morris JG, Jr, Calderwood SB, Camilli A. 2009. Cholera transmission: the host, pathogen and bacteriophage dynamic. Nat. Rev. Microbiol. 7: 693-702.
36. Nielsen AT, et al. 2006. RpoS controls the Vibrio cholerae mucosal escape response. PLoS Pathog. 2: e109. doi: 10.1371/journal.ppat.0020109.
37. Ninin E, et al. 2000. Nontoxigenic Vibrio cholerae O1 bacteremia: case report and review. Eur. J. Clin. Microbiol. Infect. Dis. 19: 489-491.
38. Nygren E, Li BL, Holmgren J, Attridge SR. 2009. Establishment of an adult mouse model for direct evaluation of the efficacy of vaccines against Vibrio cholerae. Infect. Immun. 77: 3475-3484.
39. Olivier V, Haines GK III, Tan Y, Satchell KJ. 2007. Hemolysin and the multifunctional autoprocessing RTX toxin are virulence factors during intestinal infection of mice with Vibrio cholerae El Tor O1 strains. Infect. Immun. 75: 5035-5042.
40. Olivier V, Queen J, Satchell KJ. 2009. Successful small intestine colonization of adult mice by Vibrio cholerae requires ketamine anesthesia and accessory toxins. PLoS One 4: e7352. doi: 10.1371/journal.pone.0007352.
41. Olivier V, Salzman NH, Satchell KJ. 2007. Prolonged colonization of mice by Vibrio cholerae El Tor O1 depends on accessory toxins. Infect. Immun. 75: 5043-5051.
42. Patel NM, et al. 2009. Vibrio cholerae non-O1 infection in cirrhotics: case report and literature review. Transpl. Infect. Dis. 11: 54-56.
43. Qadri F, et al. 2004. Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut. Gut 53: 62-69.
44. Qadri F, et al. 2002. Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139. Clin. Diagn. Lab. Immunol. 9: 221-229.
45. Restrepo D, Huprikar SS, VanHorn K, Bottone EJ. 2006. O1 and non-O1 Vibrio cholerae bacteremia produced by hemolytic strains. Diagn. Microbiol. Infect. Dis. 54: 145-148.
46. Rolfs A, et al. 2008. Production and sequence validation of a complete full-length ORF collection for the pathogenic bacterium Vibrio cholerae. Proc. Natl. Acad. Sci. U. S. A. 105: 4364-4369.
47. Rui H, et al. 2010. Reactogenicity of live-attenuated Vibrio cholerae vaccines is dependent on flagellins. Proc. Natl. Acad. Sci. U. S. A. 107: 4359-4364.
48. Sack DA, Sack RB, Nair GB, Siddique AK. 2004. Cholera. Lancet 363: 223-233.
49. Saha PK, et al. 1996. Nontoxigenic Vibrio cholerae O1 serotype Inaba biotype El Tor associated with a cluster of cases of cholera in southern India. J. Clin. Microbiol. 34: 1114-1117.
50. Satchell KJ. 2003. Activation and suppression of the proinflammatory immune response by Vibrio cholerae toxins. Microbes Infect. 5: 1241-1247.
51. Shi J, Gilbert GE, Kokubo Y, Ohashi T. 2001. Role of the liver in regulating numbers of circulating neutrophils. Blood 98: 1226-1230.
52. Syed KA, et al. 2009. The Vibrio cholerae flagellar regulatory hierarchy controls expression of virulence factors. J. Bacteriol. 191: 6555-6570.
53. Szabo G, Romics L, Jr, Frendl G. 2002. Liver in sepsis and systemic inflammatory response syndrome. Clin. Liver Dis. 6: 1045-1066.
54. Valeva A, et al. 2008. Proinflammatory feedback activation cycle evoked by attack of Vibrio cholerae cytolysin on human neutrophil granulocytes. Med. Microbiol. Immunol. 197: 285-293.
55. Vogt AP, et al. 2010. Acute cholecystitis caused by nontoxigenic Vibrio cholerae O1 Inaba. J. Clin. Microbiol. 48: 1002-1004.